Map of Unwanted Loneliness

Creating a map of the magnitude of the problem and the response of primary care to unwanted loneliness among the elderly, stratifying different needs based on place of residence and proximity to available assistance programs to address this issue, which, due to its scale, calls for collaboration among various institutions, disciplines, and experiences.

Study Overview

• Status: Completed
• Conditions: Loneliness
• Intervention / Treatment: Other: Exploration of a database

• Study Type: Observational
• Enrollment (Actual): 992

Contacts and Locations

Study Locations

• Spain
  • Alicante, Spain
    • FISABIO

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Population aged 65 or older who attend one of the 10 primary care centers participating in the provinces of Alicante and Valencia between March 1, 2022, and December 31, 2023.

Description

Inclusion Criteria:

• Population aged 65 or older.
• Registration of medical records related to unanticipated loneliness.
• Patients with diagnoses of anxiety disorders (CIE-10 F41.1, F41.2, F41.8, F41.9, F43.2, F45, F48) or insomnia (CIE-10 F51) or affective disorders (CIE-10 F34.1) or somatization (CIE-10 F45.0) or pathological grief (CIE-10 Z63.4) or those referred to mental health or social worker services.

Exclusion Criteria:

• None

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
NH	Number of hospitalizations	21 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
NFMV	Number of family medicine visits	21 months
NPCNV	Number of primary care nursing visits	21 months
NPSWV	Number of primary care social work visits	21 months
NFPV	Number of primary care physiotherapy visits	21 months
NCPHV	Number of primary care home consultations	21 months
NCEPV	Number of primary care emergency consultations	21 months
NHD	Number of hospitalization days	21 months
NTDMGE	Number of total daily medications (general and related to emotional condition)	21 months
NTEM	Number of total daily medications (related only to emotional condition)	21 months

Collaborators and Investigators

• Sponsor: José Joaquín Mira Solves
• Collaborators: Centro Internacional para la Investigación del Envejecimiento

Study record dates

Study Major Dates

• Study Start (Actual): May 1, 2022
• Primary Completion (Actual): November 30, 2023
• Study Completion (Actual): December 31, 2023

Study Registration Dates

• First Submitted: December 4, 2023
• First Submitted That Met QC Criteria: December 4, 2023
• First Posted (Actual): December 12, 2023

Study Record Updates

• Last Update Posted (Actual): April 1, 2025
• Last Update Submitted That Met QC Criteria: March 26, 2025
• Last Verified: March 1, 2025

More Information

Terms related to this study

• Other Study ID Numbers: UGP-23-189

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No